Sanofi

Analyst ranks the top 11 pharma giants' prospects, putting GSK on top
Fierce Biotech
Wed, 11/6/13 - 10:39 am
GSK
Bayer
Sanofi
Novartis
JNJ
Bristol-Myers Squibb
Merck
AbbVie
Eli Lilly
Pfizer
AstraZeneca
Roche Pacing the Field in the Biotech Race
TheStreet.com
Wed, 11/6/13 - 08:20 am
Roche
Amgen
Gilead
Sanofi
Celgene
These 2 Businesses Could Boost Sanofi's Top Line
Motley Fool
Sun, 11/3/13 - 12:10 pm
Sanofi
diabetes
orphan drugs
1 Big Pharma Giant on the Verge of a Turnaround
Motley Fool
Sat, 11/2/13 - 11:58 am
Sanofi
The Wisdom -- And Risk -- Of Pfizer's New Cholesterol Drug Development Plan
Forbes
Fri, 11/1/13 - 08:28 am
Pfizer
PCSK9 inhibitors
RN-316
Sanofi
Regeneron
REGN727
AMG145
Amgen
Sanofi Profit Forecast Eases Concern After Setbacks
Bloomberg
Wed, 10/30/13 - 09:42 am
Sanofi
guidance
The Value Of Sanofi Lies In Its Predictability
Seeking Alpha
Tue, 10/29/13 - 09:32 am
Sanofi
Top 10 Drug Patent Losses of 2014
Fierce Pharma
Mon, 10/28/13 - 10:26 am
patents
Copaxone
Teva
Nexium
AstraZeneca
Micardis
Boehringer Ingelheim
Sandostatin LAR
Novartis
Exforge
Nasonex
Merck
TriLipix
AbbVie
Evista
Eli Lilly
Restasis
Allergan
Renagel
Sanofi
Diabetes Giants Battle Outside of Their Usual Arena
Motley Fool
Thu, 10/24/13 - 11:29 am
Novo Nordisk
diabetes
Merck
Sanofi
NovoSeven
JNJ
3 Orphan Drugmakers to Watch
Motley Fool
Wed, 10/23/13 - 08:43 am
orphan drugs
Biomarin
GSK
Vimizim
Tafinlar
Mekinist
Myozyme
Cerazyme
Sanofi
The Next Cholesterol-Fighting Blockbuster Drug?
Motley Fool
Sun, 10/20/13 - 02:44 pm
cholesterol
hypercholesterolemia
Regeneron
Sanofi
alirocumab
Atchoo! Who’s making money out of flu season
CNBC
Fri, 10/18/13 - 09:34 am
Flu
Novartis
GSK
Merck
Sanofi
AstraZeneca
Sanofi Cholesterol Drug Beats Merck’s Zetia in Late-Stage Study
Bloomberg
Wed, 10/16/13 - 08:03 am
Sanofi
Zetia
Merck
alirocumab
Regeneron
Can Protalix Revolutionize This Orphan Disease?
Motley Fool
Tue, 10/15/13 - 05:01 pm
orphan drugs
Protalix BioTherapeutics
Gaucher disease
Vpriv
Shire
Sanofi
Genzyme
Cerezyme
Elelyso
What Drugs? Sanofi Battles Employees In France Over R&D Job Cuts
Pharmalot
Tue, 10/15/13 - 10:21 am
Sanofi
layoffs
R&D
Sanofi's home market France may be its biggest handicap
Reuters
Mon, 10/14/13 - 11:23 am
Sanofi
R&D
France
Top 10 Drugmakers in Emerging Markets
Fierce Pharma
Mon, 10/14/13 - 10:31 am
emerging markets
Bayer
Sanofi
Merck KGaA
GSK
Novartis
JNJ
Novo Nordisk
AstraZeneca
Pfizer
Roche
Sanofi gets US OK for nonprescription Nasacort
Bloomberg/Businessweek
Mon, 10/14/13 - 08:59 am
Sanofi
OTC
Nasacort
How the Game Changed Against Big Pharma - Creating New Opportunities
Forbes
Wed, 10/9/13 - 03:58 pm
Merck
Pfizer
Eli Lilly
Big Pharma
Sanofi
Roche
GSK
Abbott Laboratories
Melinta Therapeutics
antibiotics
delafloxacin
Ex-Celgene, Sanofi execs plead guilty on insider trading charges
Fierce Biotech
Wed, 10/9/13 - 11:28 am
insider trading
Sanofi
Celgee

Pages